Home LiteratureArticle Details
PMID: 23579243 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Molecular mechanisms of natural killer cell activation in response to cellular stress.

Cell death and differentiation ·Vol. 21 ·No. 1 ·2014-01-00 ·Pages 5-14

Chan CJ, Smyth MJ, Martinet L

Abstract

Protection against cellular stress from various sources, such as nutritional, physical, pathogenic, or oncogenic, results in the induction of both intrinsic and extrinsic cellular protection mechanisms that collectively limit the damage these insults inflict on the host. The major extrinsic protection mechanism against cellular stress is the immune system. Indeed, it has been well described that cells that are stressed due to association with viral infection or early malignant transformation can be directly sensed by the immune system, particularly natural killer (NK) cells. Although the ability of NK cells to directly recognize and respond to stressed cells is well appreciated, the mechanisms and the breadth of cell-intrinsic responses that are intimately linked with their activation are only beginning to be uncovered. This review will provide a brief introduction to NK cells and the relevant receptors and ligands involved in direct responses to cellular stress. This will be followed by an in-depth discussion surrounding the various intrinsic responses to stress that can naturally engage NK cells, and how therapeutic agents may induce specific activation of NK cells and other innate immune cells by activating cellular responses to stress.

MeSH Terms
Heat-Shock Proteins/metabolism Humans Immune System/immunology Killer Cells, Natural/cytology,immunology,metabolism Ligands MicroRNAs/metabolism Neoplasms/immunology,metabolism,pathology Oncogenes Receptors, Natural Killer Cell/metabolism Stress, Physiological/immunology Tumor Suppressor Proteins/metabolism Virus Diseases/immunology,metabolism,pathology
Chemicals
Heat-Shock Proteins Ligands MicroRNAs Receptors, Natural Killer Cell Tumor Suppressor Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Chan C J
1] Cellular Immunity Laboratory, Cancer Immunology Program, Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Australia [2] Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia [3] Department of Immunology, Monash University, AMREP, Prahran, Australia.
Smyth M J
Martinet L
References (145)
145 references, click to expand
  1. Up on the tightrope: natural killer cell activation and inhibition.
    Nat Immunol. 2008 May;9(5):495-502 PMID: 18425106
  2. Ras activation induces expression of Raet1 family NK receptor ligands.
    J Immunol. 2012 Aug 15;189(4):1826-34 PMID: 22798674
  3. Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication.
    J Virol. 2005 Jul;79(14):8802-11 PMID: 15994774
  4. p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines.
    Mol Cell Biol. 2008 Nov;28(21):6557-67 PMID: 18779317
  5. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
    J Exp Med. 2003 Aug 18;198(4):557-67 PMID: 12913096
  6. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases.
    Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15824-9 PMID: 14668429
  7. Calreticulin exposure dictates the immunogenicity of cancer cell death.
    Nat Med. 2007 Jan;13(1):54-61 PMID: 17187072
  8. Heat shock protein 70-associated peptides elicit specific cancer immunity.
    J Exp Med. 1993 Oct 1;178(4):1391-6 PMID: 8376942
  9. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.
    Nat Immunol. 2008 Sep;9(9):1065-73 PMID: 18677316
  10. Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance.
    Cancer Res. 2006 Jan 1;66(1):563-70 PMID: 16397273
  11. Limiting the proliferation of polyploid cells.
    Cell. 2007 Nov 2;131(3):437-40 PMID: 17981108
  12. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
    Cancer Res. 2011 Sep 15;71(18):5998-6009 PMID: 21764762
  13. Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biology.
    Cold Spring Harb Symp Quant Biol. 2008;73:513-22 PMID: 19150958
  14. Unique functional status of natural killer cells in metastatic stage IV melanoma patients and its modulation by chemotherapy.
    Clin Cancer Res. 2011 May 1;17(9):2628-37 PMID: 21224372
  15. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
    Nature. 2006 Nov 30;444(7119):638-42 PMID: 17136094
  16. Perforin is a major contributor to NK cell control of tumor metastasis.
    J Immunol. 1999 Jun 1;162(11):6658-62 PMID: 10352283
  17. Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells.
    J Immunol. 1999 Apr 1;162(7):3757-60 PMID: 10201889
  18. Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.
    Cell Cycle. 2011 Oct 1;10(19):3346-58 PMID: 21941086
  19. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    J Immunol. 2003 Dec 15;171(12):6891-9 PMID: 14662896
  20. Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells.
    Immunity. 2011 Oct 28;35(4):456-66 PMID: 22035838
  21. Soluble MICA in malignant diseases.
    Int J Cancer. 2006 Feb 1;118(3):684-7 PMID: 16094621
  22. eIF4E--from translation to transformation.
    Oncogene. 2004 Apr 19;23(18):3172-9 PMID: 15094766
  23. Hallmarks of cancer: the next generation.
    Cell. 2011 Mar 4;144(5):646-74 PMID: 21376230
  24. CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules.
    Eur J Immunol. 1993 Oct;23(10):2454-63 PMID: 8405045
  25. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.
    Immunity. 2008 Apr;28(4):571-80 PMID: 18394936
  26. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.
    Blood. 2007 Jul 15;110(2):606-15 PMID: 17405908
  27. Natural killer cell recognition of missing self.
    Nat Immunol. 2008 May;9(5):477-80 PMID: 18425103
  28. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
    Cell. 1997 Mar 7;88(5):593-602 PMID: 9054499
  29. An immunosurveillance mechanism controls cancer cell ploidy.
    Science. 2012 Sep 28;337(6102):1678-84 PMID: 23019653
  30. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.
    J Exp Med. 2011 Mar 14;208(3):491-503 PMID: 21383056
  31. Manipulation of the host translation initiation complex eIF4F by DNA viruses.
    Biochem Soc Trans. 2010 Dec;38(6):1511-6 PMID: 21118117
  32. Cytotoxicity of activated natural killer cells against pediatric solid tumors.
    Clin Cancer Res. 2010 Aug 1;16(15):3901-9 PMID: 20542985
  33. Intrinsic tumour suppression.
    Nature. 2004 Nov 18;432(7015):307-15 PMID: 15549092
  34. Functional interactions between dendritic cells and NK cells during viral infection.
    Nat Immunol. 2003 Feb;4(2):175-81 PMID: 12496964
  35. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    Cancer Res. 2007 Sep 15;67(18):8444-9 PMID: 17875681
  36. The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy.
    Blood. 2011 Feb 3;117(5):1605-13 PMID: 20978269
  37. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.
    Nature. 2001 Sep 13;413(6852):165-71 PMID: 11557981
  38. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.
    Nature. 2002 Oct 17;419(6908):734-8 PMID: 12384702
  39. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer.
    J Clin Invest. 2004 Aug;114(4):560-8 PMID: 15314693
  40. Differential tumor surveillance by natural killer (NK) and NKT cells.
    J Exp Med. 2000 Feb 21;191(4):661-8 PMID: 10684858
  41. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress.
    J Exp Med. 2009 Feb 16;206(2):287-98 PMID: 19171762
  42. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.
    J Clin Oncol. 2010 Jan 1;28(1):105-13 PMID: 19917869
  43. Self-tolerance of natural killer cells.
    Nat Rev Immunol. 2006 Jul;6(7):520-31 PMID: 16799471
  44. Molecular chaperones in the cytosol: from nascent chain to folded protein.
    Science. 2002 Mar 8;295(5561):1852-8 PMID: 11884745
  45. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.
    Immunity. 2001 Feb;14(2):123-33 PMID: 11239445
  46. Mammalian microRNAs predominantly act to decrease target mRNA levels.
    Nature. 2010 Aug 12;466(7308):835-40 PMID: 20703300
  47. Accelerated tumor growth in mice deficient in DNAM-1 receptor.
    J Exp Med. 2008 Dec 22;205(13):2959-64 PMID: 19029379
  48. The DNA damage response arouses the immune system.
    Cancer Res. 2006 Apr 15;66(8):3959-62 PMID: 16618710
  49. Role of the heat shock response and molecular chaperones in oncogenesis and cell death.
    J Natl Cancer Inst. 2000 Oct 4;92(19):1564-72 PMID: 11018092
  50. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells.
    J Immunol. 1997 May 1;158(9):4341-50 PMID: 9126997
  51. OncomiRs: the discovery and progress of microRNAs in cancers.
    Mol Cancer. 2007 Sep 25;6:60 PMID: 17894887
  52. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.
    Nat Med. 2009 Oct;15(10):1170-8 PMID: 19767732
  53. The role of the NKG2D immunoreceptor in immune cell activation and natural killing.
    Immunity. 2002 Jul;17(1):19-29 PMID: 12150888
  54. ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells.
    Blood. 2013 Mar 28;121(13):2512-21 PMID: 23349395
  55. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.
    PLoS Pathog. 2011 Sep;7(9):e1002265 PMID: 21966273
  56. The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands.
    J Immunol. 2007 Oct 15;179(8):5523-33 PMID: 17911639
  57. Roles of the NKG2D immunoreceptor and its ligands.
    Nat Rev Immunol. 2003 Oct;3(10):781-90 PMID: 14523385
  58. Senescence of activated stellate cells limits liver fibrosis.
    Cell. 2008 Aug 22;134(4):657-67 PMID: 18724938
  59. MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells.
    Cancer Res. 2012 Nov 1;72(21):5463-72 PMID: 22915757
  60. Effect of NKG2D ligand expression on host immune responses.
    Immunol Rev. 2010 May;235(1):267-85 PMID: 20536569
  61. Senescence comes of age.
    Nat Med. 2005 Sep;11(9):920-2 PMID: 16145569
  62. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
    Nat Immunol. 2000 Aug;1(2):119-26 PMID: 11248803
  63. Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance.
    Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1686-91 PMID: 18223157
  64. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
    J Clin Invest. 2009 May;119(5):1251-63 PMID: 19349689
  65. MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.
    Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1285-90 PMID: 18202175
  66. Immunogenic cell death in cancer therapy.
    Annu Rev Immunol. 2013;31:51-72 PMID: 23157435
  67. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.
    Semin Cancer Biol. 2006 Oct;16(5):359-66 PMID: 16904340
  68. Heat shock proteins and immune system.
    J Leukoc Biol. 2009 Jun;85(6):905-10 PMID: 19276179
  69. Releasing signals, secretory pathways, and immune function of endogenous extracellular heat shock protein 72.
    J Leukoc Biol. 2006 Mar;79(3):425-34 PMID: 16387837
  70. Granule exocytosis mediates immune surveillance of senescent cells.
    Oncogene. 2013 Apr 11;32(15):1971-7 PMID: 22751116
  71. Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells.
    Retrovirology. 2009 Jan 15;6:5 PMID: 19146679
  72. Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors.
    Cancer Res. 2008 Mar 1;68(5):1546-54 PMID: 18316620
  73. Natural killer cells, viruses and cancer.
    Nat Rev Immunol. 2001 Oct;1(1):41-9 PMID: 11905813
  74. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Nat Immunol. 2002 Dec;3(12):1150-5 PMID: 12426564
  75. Cancer immunotherapy using NKG2D and DNAM-1 systems.
    Anticancer Res. 2012 Jun;32(6):2241-7 PMID: 22641658
  76. The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence.
    Cancer Discov. 2013 Jan;3(1):82-95 PMID: 23242809
  77. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.
    Cancer Res. 2012 Jan 15;72(2):460-71 PMID: 22102694
  78. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    J Immunol. 2002 May 15;168(10):5047-57 PMID: 11994457
  79. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network.
    Cell. 2008 Jun 13;133(6):1019-31 PMID: 18555778
  80. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
    Science. 1999 Jul 30;285(5428):727-9 PMID: 10426993
  81. Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability.
    Oncogene. 2003 Sep 29;22(42):6508-16 PMID: 14528275
  82. The TRAIL apoptotic pathway in cancer onset, progression and therapy.
    Nat Rev Cancer. 2008 Oct;8(10):782-98 PMID: 18813321
  83. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.
    Nature. 2005 Aug 25;436(7054):1186-90 PMID: 15995699
  84. Cytoplasmic functions of the tumour suppressor p53.
    Nature. 2009 Apr 30;458(7242):1127-30 PMID: 19407794
  85. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.
    Int Immunol. 2001 Apr;13(4):459-63 PMID: 11282985
  86. ATM and related protein kinases: safeguarding genome integrity.
    Nat Rev Cancer. 2003 Mar;3(3):155-68 PMID: 12612651
  87. The role of Myc-induced protein synthesis in cancer.
    Cancer Res. 2009 Dec 1;69(23):8839-43 PMID: 19934336
  88. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding.
    J Immunol. 2002 Oct 15;169(8):4098-102 PMID: 12370336
  89. Chemokine signaling via the CXCR2 receptor reinforces senescence.
    Cell. 2008 Jun 13;133(6):1006-18 PMID: 18555777
  90. SHP-2 expression negatively regulates NK cell function.
    J Immunol. 2009 Dec 1;183(11):7234-43 PMID: 19915046
  91. Natural killer cells in viral infection: more than just killers.
    Immunol Rev. 2006 Dec;214:239-50 PMID: 17100889
  92. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
    Nat Med. 2007 Sep;13(9):1050-9 PMID: 17704786
  93. MYC on the path to cancer.
    Cell. 2012 Mar 30;149(1):22-35 PMID: 22464321
  94. Class I PI3K in oncogenic cellular transformation.
    Oncogene. 2008 Sep 18;27(41):5486-96 PMID: 18794883
  95. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141.
    Nat Immunol. 2005 Feb;6(2):181-8 PMID: 15640804
  96. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
    J Immunol. 2003 May 1;170(9):4539-47 PMID: 12707331
  97. Regulation of ligands for the NKG2D activating receptor.
    Annu Rev Immunol. 2013;31:413-41 PMID: 23298206
  98. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.
    Immunity. 2000 Jun;12(6):721-7 PMID: 10894171
  99. Dendritic cells prime natural killer cells by trans-presenting interleukin 15.
    Immunity. 2007 Apr;26(4):503-17 PMID: 17398124
  100. The functions of animal microRNAs.
    Nature. 2004 Sep 16;431(7006):350-5 PMID: 15372042
  101. Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition.
    Cancer Res. 2011 Nov 1;71(21):6621-32 PMID: 21937679
  102. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes.
    Immunity. 1996 Jun;4(6):573-81 PMID: 8673704
  103. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.
    J Immunol. 2002 Oct 15;169(8):4079-83 PMID: 12370332
  104. Resistance to viral infection of super p53 mice.
    Oncogene. 2005 Apr 21;24(18):3059-62 PMID: 17726827
  105. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte.
    Cell. 2005 Oct 21;123(2):321-34 PMID: 16239148
  106. Cloning of new members of heat shock protein HSP101 gene family in wheat (Triticum aestivum (L.) Moench) inducible by heat, dehydration, and ABA(1).
    Biochim Biophys Acta. 2001 Jan 26;1517(2):270-7 PMID: 11342108
  107. Heat shock protein 70 (hsp70) as an emerging drug target.
    J Med Chem. 2010 Jun 24;53(12):4585-602 PMID: 20334364
  108. Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA.
    Cancer Immunol Immunother. 2006 Dec;55(12):1584-9 PMID: 16636811
  109. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene.
    Nat Genet. 1997 Oct;17(2):141-3 PMID: 9326928
  110. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).
    Blood. 2005 Mar 1;105(5):2066-73 PMID: 15536144
  111. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.
    Eur J Immunol. 2001 Apr;31(4):1076-86 PMID: 11298332
  112. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
    Nature. 2006 Nov 30;444(7119):633-7 PMID: 17136093
  113. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro.
    J Biol Chem. 2012 May 4;287(19):15874-85 PMID: 22396543
  114. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.
    Nat Immunol. 2011 Aug 28;12(10):975-83 PMID: 21874023
  115. Transcriptional role of p53 in interferon-mediated antiviral immunity.
    J Exp Med. 2008 Aug 4;205(8):1929-38 PMID: 18663127
  116. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.
    J Clin Invest. 2011 Sep;121(9):3609-22 PMID: 21841316
  117. Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.
    Cancer Res. 2011 Jul 15;71(14):4809-20 PMID: 21646474
  118. Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.
    Curr Opin Immunol. 2012 Apr;24(2):246-51 PMID: 22285893
  119. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases.
    J Immunol. 2010 Jan 15;184(2):902-11 PMID: 20008292
  120. The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway.
    Nat Rev Microbiol. 2008 Apr;6(4):266-75 PMID: 18311165
  121. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors.
    J Exp Med. 2008 Dec 22;205(13):2965-73 PMID: 19029380
  122. Oncogenic stress sensed by the immune system: role of natural killer cell receptors.
    Nat Rev Immunol. 2009 Aug;9(8):568-80 PMID: 19629084
  123. Functions of natural killer cells.
    Nat Immunol. 2008 May;9(5):503-10 PMID: 18425107
  124. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.
    Nature. 2007 Feb 8;445(7128):656-60 PMID: 17251933
  125. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
    Mol Immunol. 2005 Feb;42(4):463-9 PMID: 15607800
  126. TLiSA1 (PTA1) activation antigen implicated in T cell differentiation and platelet activation is a member of the immunoglobulin superfamily exhibiting distinctive regulation of expression.
    J Biol Chem. 1997 Aug 29;272(35):21735-44 PMID: 9268302
  127. Natural killer cell signaling pathways.
    Science. 2004 Nov 26;306(5701):1517-9 PMID: 15567854
  128. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses.
    Annu Rev Immunol. 2002;20:395-425 PMID: 11861608
  129. The essence of senescence.
    Genes Dev. 2010 Nov 15;24(22):2463-79 PMID: 21078816
  130. NKG2D function protects the host from tumor initiation.
    J Exp Med. 2005 Sep 5;202(5):583-8 PMID: 16129707
  131. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells.
    J Immunol. 2004 Jan 15;172(2):972-80 PMID: 14707070
  132. RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry.
    J Exp Med. 2012 Dec 17;209(13):2409-22 PMID: 23166357
  133. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.
    Blood. 2009 Apr 9;113(15):3503-11 PMID: 19098271
  134. Dual Role of p53 in Innate Antiviral Immunity.
    Viruses. 2010 Jan;2(1):298-313 PMID: 21994612
  135. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB.
    Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6879-84 PMID: 10359807
  136. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus.
    Immunity. 2006 Jun;24(6):779-786 PMID: 16782033
  137. Roles of heat-shock proteins in innate and adaptive immunity.
    Nat Rev Immunol. 2002 Mar;2(3):185-94 PMID: 11913069
  138. A DNA damage checkpoint response in telomere-initiated senescence.
    Nature. 2003 Nov 13;426(6963):194-8 PMID: 14608368
  139. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.
    Nature. 2005 Apr 14;434(7035):907-13 PMID: 15829965
  140. The anticancer immune response: indispensable for therapeutic success?
    J Clin Invest. 2008 Jun;118(6):1991-2001 PMID: 18523649
  141. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.
    Blood. 2011 May 5;117(18):4778-86 PMID: 21406724
  142. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity.
    J Immunol. 2001 Dec 15;167(12):6731-5 PMID: 11739487
  143. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.
    Cancer Res. 2005 Jun 15;65(12):5238-47 PMID: 15958569
  144. Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis.
    Clin Sarcoma Res. 2012 Feb 08;2(1):8 PMID: 22587892
  145. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.
    Biol Chem. 2003 Feb;384(2):267-79 PMID: 12675520
Article Info
Journal
Cell death and differentiation
Abbr.
Cell Death Differ
ISSN
1476-5403
Published
2014-01-00
Epub
2013-00-12
Pages
5-14
Language
English
Region
England
NLM ID
9437445
PMCID
PMC3857624
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com